Abstract
Data on the contribution of gene polymorphism of proteins and enzymes of aldosterone metabolism to arterial hypertension are considered. On the basis of the analysis of scientific papers (eLIBRARY.RU, PubMed) and open databases (NCBI, GeneCard, QIAGEN, and related resources), the current status of ideas about the aldosterone metabolism genes (STAR, CYP11A1, HSD3B1, CYP21A2, CYP11B1, CYP11B2, UGT2B7), their expression, polymorphism, and the effect of the genetic variability on the encoded product was assessed. The role of the balance of aldosterone precursors in the regulation of blood pressure and the mutual influence of mineralocorticoids during aldosterone biogenesis on the final product of the reaction were analyzed. The main discussions on the studied issue were noted.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
